Legend Biotech Corp (LEGN)
40.94
+1.19
(+2.99%)
USD |
NASDAQ |
Nov 22, 16:00
40.95
+0.01
(+0.02%)
After-Hours: 20:00
Legend Biotech Profit Margin (Quarterly): -78.23% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -78.23% |
| June 30, 2024 | -9.76% |
| March 31, 2024 | -63.62% |
| December 31, 2023 | -182.2% |
| September 30, 2023 | -64.79% |
| June 30, 2023 | -271.6% |
| March 31, 2023 | -308.5% |
| December 31, 2022 | -491.7% |
| September 30, 2022 | -310.5% |
| June 30, 2022 | -1.61K% |
| March 31, 2022 | -64.53% |
| December 31, 2021 | -586.3% |
| Date | Value |
|---|---|
| September 30, 2021 | -742.8% |
| June 30, 2021 | -452.6% |
| March 31, 2021 | |
| December 31, 2020 | -51.67% |
| September 30, 2020 | -566.5% |
| June 30, 2020 | -1.16K% |
| March 31, 2020 | -383.1% |
| December 31, 2019 | -328.8% |
| September 30, 2019 | -157.3% |
| June 30, 2019 | -285.5% |
| March 31, 2019 | -123.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.61K%
Minimum
Jun 2022
-9.76%
Maximum
Jun 2024
-407.1%
Average
-310.5%
Median
Sep 2022
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 11.99% |
| Ligand Pharmaceuticals Inc | -13.84% |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -10.57K% |
| IGC Pharma Inc | -416.7% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -28.87% |
| Return on Assets | -19.35% |
| Return on Invested Capital | -23.33% |
| Gross Profit Margin (Quarterly) | 65.38% |
| Operating Margin (Quarterly) | -43.73% |
| Return on Net Operating Assets | -43.69% |